Search

Your search keyword '"Eiger, D"' showing total 5 results
Start Over Author "Eiger, D" Topic metastatic breast cancer
5 results on '"Eiger, D"'

1. 348P First findings from SYNERGY, a phase I/II trial testing the addition of the anti-CD73 oleclumab (O) to the anti-PD-L1 durvalumab (D) and chemotherapy (ChT) as first line therapy for patients (pts) with metastatic triple-negative breast cancer (mTNBC)

Author

Eiger, D., Maurer, C., Brandao, M., Aftimos, P.G., Punie, K., Taylor, D., Van den Mooter, T., Poncin, R., Canon, J-L., Duhoux, F., Casert, V., Clatot, F., Velghe, C., Craciun, L., Paesmans, M., de Azambuja, E., Ignatiadis, M., Larsimont, D., Piccart, M., and Buisseret, L.

Subjects
*METASTATIC breast cancer, *TRIPLE-negative breast cancer, *CANCER chemotherapy
Published
2020
Full Text
View/download PDF

2. 195TiP SYNERGY: Phase I and randomized phase II trial to investigate the addition of the anti-CD73 antibody oleclumab to durvalumab, paclitaxel and carboplatin for previously untreated, locally recurrent inoperable or metastatic triple-negative breast cancer (TNBC)

Author

Maurer, C, Eiger, D, Velghe, C, Aftimos, P G, Maetens, M, Gaye, J, Paesmans, M, Ignatiadis, M, Piccart, M, and Buisseret, L

Subjects
*PACLITAXEL, *CARBOPLATIN, *THERAPEUTICS, *PROGRESSION-free survival, *IMMUNOGLOBULINS, *METASTATIC breast cancer
Published
2019
Full Text
View/download PDF

4. Corrigendum to "Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials": Annals of Oncology 2020; volume 31, supplement 2; s71 (abstr. 153P)

Author

Franzoi, M.A., Ameye, L., Eiger, D., Piccart, M., Brandão, M.D.R.A., Pondé, N., Desmedt, C., Di Cosimo, S., Paesmans, M., Caparica, R., Kotecki, N., Lambertini, M., De Angelis, C., Awada, A.H., and de Azambuja, E.

Subjects
*BODY mass index, *METASTATIC breast cancer, *HORMONE therapy
Published
2020
Full Text
View/download PDF

5. 153P Clinical implications of body mass index (BMI) and weight in metastatic breast cancer (BC) patients treated with abemaciclib and endocrine therapy: A pooled individual patient level data analysis of MONARCH 2 and MONARCH 3 trials.

Author

Franzoi, M.A., Ameye, L., Eiger, D., Piccart, M., Brandão, M.D.R.A., Pondé, N., Desmedt, C., Di Cosimo, S., Paesmans, M., Caparica, R., Kotecki, N., Lambertini, M., De Angelis, C., Awada, A.H., and de Azambuja, E.

Subjects
*METASTATIC breast cancer, *BODY mass index, *CANCER hormone therapy, *CLINICAL trials, *DATA analysis
Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results